Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

To: stockdoc77 who wrote (63087)	4/16/2025 11:56:59 AM
From: galt	4 Recommendations Read Replies (1) of 63285

I'd like to make some political observations about Patrick also but have held off on doing soo to avoid puking all over myself. IBRX, however, has FDA approval for Anktiva in one cancer and, unless Patrick is outright lying, it looks that Anktiva could soon get approved for other cancer types. Very much like IMMU, hard to stay focused on the drug when the founder is, to be kind, over the edge. Of course, IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next